D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 17.47 CNY -2.02% Market Closed
Market Cap: 19.9B CNY

DaShenLin Pharmaceutical Group Co Ltd's latest stock split occurred on Jun 9, 2023

The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.

Before the split, DaShenLin Pharmaceutical Group Co Ltd traded at 26.3583 per share. Afterward, the share price was about 26.84.

The adjusted shares began trading on Jun 9, 2023. This was DaShenLin Pharmaceutical Group Co Ltd's 5th stock split, following the previous one in Jun 13, 2022.

Last Splits:
Jun 9, 2023
6-for-5
Jun 13, 2022
6-for-5
Jun 10, 2021
6-for-5
Jun 17, 2020
6-for-5
May 30, 2019
13-for-10
Pre-Split Price
25.7583 26.3583
Post-Split Price
26.84
Before
After
Last Splits:
Jun 9, 2023
6-for-5
Jun 13, 2022
6-for-5
Jun 10, 2021
6-for-5
Jun 17, 2020
6-for-5
May 30, 2019
13-for-10

DaShenLin Pharmaceutical Group Co Ltd
Stock Splits History

DaShenLin Pharmaceutical Group Co Ltd Stock Splits Timeline
Jun 9, 2023
Jun 9, 2023
Split 6-for-5
x1.2
Pre-Split Price
25.7583 26.3583
Post-Split Price
26.84
Before
After
Jun 13, 2022
Jun 13, 2022
Split 6-for-5
x1.2
Pre-Split Price
27.4917 27.9917
Post-Split Price
28.5
Before
After
Jun 10, 2021
Jun 10, 2021
Split 6-for-5
x1.2
Pre-Split Price
45.5535 67.75
Post-Split Price
46.5451
Before
After
Jun 17, 2020
Jun 17, 2020
Split 6-for-5
x1.2
Pre-Split Price
49.5205 89.1
Post-Split Price
51.5779
Before
After
May 30, 2019
May 30, 2019
Split 13-for-10
x1.3
Pre-Split Price
24.275 57.5599
Post-Split Price
24.4546
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
47.5 47.5 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
81 81 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
60.6 60.6 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
47.945 47.945 USD N/A
Load More

DaShenLin Pharmaceutical Group Co Ltd
Glance View

Market Cap
19.9B CNY
Industry
Retail

DaShenLin Pharmaceutical Group Co., Ltd. is a fascinating entity woven into the intricate fabric of China's rapidly evolving healthcare landscape. Stemming from humble origins, the company has blossomed into a significant player in the pharmaceutical industry. DaShenLin's business model adeptly combines the traditional with the modern, strategically positioning itself across the supply and distribution spectrum. Primarily, it operates through an extensive retail network, boasting a formidable chain of pharmacies thoughtfully dotted across various provinces. These pharmacies are more than mere outlets; they serve as community health sanctuaries offering an array of pharmaceutical products and health consultations. The company's commitment to traditional Chinese medicine sets it apart, further establishing a niche by fusing age-old healing practices with contemporary medicinal needs. The company's revenue streams are as diverse as its product offerings. Predominantly, it derives income from the direct sale of pharmaceuticals, encompassing both Western drugs and traditional Chinese medicines. Additionally, DaShenLin capitalizes on its robust wholesale operations, providing a steady pipeline of medicinal products to regional hospitals and clinics. The company thrives on its comprehensive supply chain, which ensures an uninterrupted flow of goods from production to consumers' hands. With a keen emphasis on quality and efficacy, DaShenLin continuously invests in research and development, fostering innovation within its product lines. This strategic focus not only reinforces consumer trust but also secures its competitive edge within a dynamic market landscape.

DaShenLin Pharmaceutical Group Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top